Daniel Pfund, Senior Financial Analyst
Straumann is the world leader in dental implants with 25% market share. Over the last three years, the group’s turnover has increased by an average of 14.9% per year. This impressive growth is the direct consequence of the management’s decision to diversify from high-end implants. Indeed, the company is now present in cheaper implants, which represent about 50% of the market. In addition, the company has acquired small companies active in related fields, such as clear aligners – transparent molds that gradually straighten teeth. Finally, in the high-end segment, Straumann offers a new type of implant, the BLX, which is completely tapered. We welcome all these decisions and believe that the company will be able to continue to grow at double-digit rates in the next few years.